Skip to main content
SpringerLink
Log in

Medikamentenbeschichtete Stents

Wo stehen wir 2004?

  • EDITORIAL
  • Published:
Zeitschrift für Kardiologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fattori R, Tommaso P (2003) Drugeluting stents in vascular intervention. Lancet 361:247–249

    Article  PubMed  Google Scholar 

  2. Mannebach H, Horstkotte D (2004) 19. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol (in press)

  3. Lincoff AM, Topol EJ, Ellis SG (1994) Local drug delivery for the prevention of restenosis. Fact, fancy and future. Circulation 90:2070–2082

    CAS  PubMed  Google Scholar 

  4. Kuntz RE, Baim DS (2000) Prevention of coronary restenosis: the evolving evidence base for radiation therapy. Circulation 101:2130–2133

    CAS  PubMed  Google Scholar 

  5. Waksman R (1999) Late thrombosis after radiation. Sitting on a time bomb. Circulation 100:780–782

    CAS  PubMed  Google Scholar 

  6. Suzuki T, Kopia G, Hayashi S et al (2001) Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188–1193

    CAS  PubMed  Google Scholar 

  7. Heldman AW, Cheng L, Jenkins GM, Heller PF, Dong-Woon K, Ware M, Nater C, Hruban RH, Rezai B, Abella BS, Bunge EK, Kinsella JL, Sollott SJ, Lakatta EG, Brinker JA, Hunter WL, Froehlich JP (2001) Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103:2289–2295

    CAS  PubMed  Google Scholar 

  8. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94:1690–1697

    CAS  PubMed  Google Scholar 

  9. Cordis patent (2000) PCT/US01/15559, WO 01/87373 A1

  10. Farb A, Heller PF, Shroff S et al (2001) Pathological analysis of local delivery of paclitaxel via a polymercoated stent. Circulation 104:473–479

    CAS  PubMed  Google Scholar 

  11. FDA Public Health Web Notification (2003) Information for physicians on subacute thromboses (SAT) and hypersensitivity reactionswith use of the cordis CYPHER coronary stent. http://www.fda.gov/cdrh/safety/cypher.html

  12. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705

    Article  PubMed  Google Scholar 

  13. Chieffo A, Bonizzoni E, Orlic D, Stankovic G, Rogacka R, Airoldi F, Mikhail GW, Montorfano M, Michev I, Carlino M, Colombo A (2004) Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents. Circulation 109:2732–2736

    Article  CAS  PubMed  Google Scholar 

  14. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349(14):1315–1323

    Article  CAS  PubMed  Google Scholar 

  15. Cutlip DE, Chauhan MS, Baim DS et al (2002) Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 40:2082–2089

    Article  PubMed  Google Scholar 

  16. Greenberg D, Bakhai A, Cohen D (2004) Can we afford to eliminate restenosis? Can we afford not to? J Am Coll Cardiol 43:513–518

    Article  PubMed  Google Scholar 

  17. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymerbased paclitaxel eluting stents for coronary artery lesions. Circulation 108(7):788–794

    Article  CAS  PubMed  Google Scholar 

  18. Gershlick A, De Scheerder I, Chevalier B, Stephens-Lloyd A, Camenzind E, Vrints C, Reifart N, Missault L, Goy JJ, Brinker JA, Raizner AE, Urban P, Heldman AW (2004) Inhibition of restenosis with a paclitaxeleluting, polymer-free coronary stent: the European evaluation of paclitaxel eluting stent (ELUTES) trial. Circulation 109(4):487–493

    Article  CAS  PubMed  Google Scholar 

  19. Grube E, Silber S, Hauptmann KE et al (2003) TAXUS I: six- and twelve-month results from a randomized, double blind trial on a slow-release Paclitaxel eluting stent for de novo coronary lesions. Circulation 107:38–42

    Article  CAS  PubMed  Google Scholar 

  20. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  CAS  PubMed  Google Scholar 

  21. Park SJ, Shim WH, Ho DS et al (2003) A paclitaxel eluting stent for the prevention of coronary restenosis. N Engl J Med 348:1537–1545

    Article  CAS  PubMed  Google Scholar 

  22. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231

    Article  CAS  PubMed  Google Scholar 

  23. Mudra H, Bode C, Grube E, deHaan F, Levenson B, Schuler G, Silber S (2004) Positionspapier zum Einsatz von Medikamente freisetzenden Stents bei Patienten mit koronarer Herzerkrankung. Z Kardiol 93:416–422

    Google Scholar 

  24. Silber S (2004) Wann sind Drug-eluting Stents als wirksam zu bezeichnen? Eine kritische Analyse der aktuellen Datenlage. Z Kardiol

  25. Moderate-release Paclitaxel-eluting Stent Outshines Bare Metal in Taxus VI (2004) Heart wire, May 25, 2004, www.theheart.org

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Kardiologie, Angiologie, internistische Intensivmedizin, Direktor: Prof. Dr. med. M. Böhm, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Germany

    B. Scheller

Authors
  1. B. Scheller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheller, B. Medikamentenbeschichtete Stents. Z Kardiol 93, 646–648 (2004). https://doi.org/10.1007/s00392-004-0145-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-004-0145-6

Search

Navigation